The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition
| Autor: | Hiroji Iwata, Nami Yamashita, Fimikata Hara, Tatsuya Toyama, Rikiya Nakamura, Junji Tsurutani, Yasuaki Sagara, Toshiro Mizuno, Masaya Hattori, Shigenori Nagai, Yoichi Naito, Naoto Kondo, Hitoshi Arioka, Naoki Hayashi, Yuichiro Kikawa, Minoru Miyashita, Tatsunori Shimoi, Mikiya Ishihara, Toshimi Takano, Kei Koizumi, Masato Takahashi, Masahiro Takada, Tetsuhiro Yoshinami, Shigehira Saji, Takashi Yamanaka |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Breast Neoplasms Systemic treatment Guideline Medical Oncology 03 medical and health sciences Strength of evidence Special Article 0302 clinical medicine Breast cancer Japan medicine Humans Pharmacology (medical) Radiology Nuclear Medicine and imaging Guideline development Task force business.industry Correction General Medicine Prognosis medicine.disease Combined Modality Therapy Clinical Practice 030104 developmental biology Harm Oncology Clinical question 030220 oncology & carcinogenesis Family medicine Practice Guidelines as Topic Female business |
| Zdroj: | Breast Cancer (Tokyo, Japan) |
| ISSN: | 1880-4233 1340-6868 |
| Popis: | Purpose We present the English version of The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition. Methods The JBCS formed a task force to update the JBCS Clinical Practice Guidelines, 2015 edition, according to Minds Handbook for Clinical Practice Guideline Development 2014. First, we set multiple outcomes for each clinical question (CQ). Next, quantitative or qualitative systematic review was conducted for each of the multiple outcomes, and the strength of recommendation for the CQ was taken into consideration during meetings, with the aim of finding a balance between benefit and harm. Finalized recommendations from each session were confirmed through discussion and voting at the recommendation decision meeting. Results The recommendations, the strength of recommendation and the strength of evidence were determined based on systemic literature reviews and the meta-analyses for each CQ. Conclusion The JBCS updated the Clinical Practice Guidelines for systemic treatment of breast cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink